| Jumlah Saham Beredar | 6,993,406 shares |
| Saham Orang Dalam | 5,401,084 shares |
| Kepemilikan oleh Orang Dalam | 77.23 % |
| Orang Dalam Sejati | 32 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
5094 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
5069 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Minerva Neurosciences, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Frederick W Ahlholm SVP, CFO and Secretary - [O] | 17,518 | 17,518 | |
|
Plc Barclays
10% Owner -
|
196,800 | 196,800 | |
|
Boehringer Ingelheim International Gmbh
10% Owner -
|
2,550,000 | 2,550,000 | |
| Marc D Beer Director - [D] | 50,000 | 6,250 | |
|
Care Capital III LLC
10% Owner -
|
1,662,592 | 207,824 | |
|
Care Capital Investments III L.P.
10% Owner -
|
1,662,592 | 207,824 | |
|
Care Capital Offshore Investments III LP
10% Owner -
|
1,662,592 | 207,824 | |
| William F Doyle Director - [D] | 26,111 | 3,264 | |
| Michael Davidson Chief Medical Officer - [O] | 0 | 0 | |
|
Rubertis Francesco De
Director, 10% Owner -
[D]
|
4,690,906 | 586,363 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Hans Peter Hasler Director - [D] | 10,000 | 1,250 | |
| Jeryl L Hilleman Director - [D] | 1,000 | 125 | |
|
Venture Associates III Ltd Index
10% Owner -
|
3,899,189 | 487,399 | |
|
Venture Associates IV Ltd Index
10% Owner -
|
3,899,189 | 487,399 | |
|
Venture Associates V Ltd Index
10% Owner -
|
3,899,189 | 487,399 | |
|
& Johnson Johnson
10% Owner -
|
0 | 0 | |
|
Johnson & Johnson Innovation - JJDC, Inc.
10% Owner -
|
0 | 0 | |
| David Kupfer Director - [D] | 163,553 | 20,444 | |
| Fouzia Laghrissi-Thode Director - [D] | 0 | 0 | |
| Levine Mark S. SVP,General Counsel & Sec. - [O] | 0 | 0 | |
| Remy Luthringer CEO, Director - [D] [O] | 184,819 | 184,819 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Michele Ollier
Director, 10% Owner -
[D]
|
4,690,906 | 586,363 | |
|
Lorenzo Pellegrini
Director, 10% Owner -
[D]
|
3,883,212 | 485,402 | |
| Geoff Race President - [O] | 51,324 | 51,324 | |
| Reilly Joseph H. SVP & Chief Operating Officer - [O] | 31,747 | 3,968 | |
| Russell Richard E. President - [O] | 33,770 | 4,221 | |
| Jay Saoud | 100,000 | ||
| Devin Whittemore Smith | 85,000 | ||
| Heek G Jan Van Director - [D] | 20,333 | 2,542 | |
| Nico Vandervelpen Director - [D] | 0 | 0 | |
| Coelho Rogerio Vivaldi President and CEO, Director - [D] [O] | 41,667 | 5,208 | |
|
(Jersey) SLP Yucca
10% Owner -
|
3,899,189 | 487,399 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di NERV / Minerva Neurosciences, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di NERV / Minerva Neurosciences, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-07 | 3 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | NERV | Common Stock | D | 1,275,000 | ||||||||
| 2023-05-02 | 2023-05-02 | 4 | Luthringer Remy | NERV | Common Stock | D | 3.7600 | -3,641 | -14 | 68,994 | ||||
| 2023-05-02 | 2023-05-01 | 4 | Luthringer Remy | NERV | Common Stock | D | 3.8500 | -23,753 | -91 | 72,635 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Luthringer Remy | NERV | Common Stock | D | 88,077 | 96,388 | ||||||
| 2023-05-02 | 2023-05-01 | 4 | Race Geoff | NERV | Common Stock | D | 3.8500 | -22,082 | -85 | 51,324 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Race Geoff | NERV | Common Stock | D | 46,987 | 73,406 | ||||||
| 2023-05-02 | 2023-05-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4.4800 | -3,580 | -16 | 17,518 | ||||
| 2023-05-02 | 2023-04-28 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 19,843 | 21,098 | ||||||
| 2022-08-10 | 3 | BARCLAYS PLC By Barclays Capital Inc. | NERV | Common Stock, $0.0001 par value per share | I | 196,800 | ||||||||
| 2022-08-10 | 3 | BARCLAYS PLC By Barclays Bank PLC | NERV | Common Stock, $0.0001 par value per share | I | 408,430 | ||||||||
| 2022-02-18 | 2022-02-16 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 0.79 | 180,000 | 180,000 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 0.79 | 505,000 | 505,000 | |||||
| 2022-02-18 | 2022-02-16 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 0.79 | 200,000 | 200,000 | |||||
| 2021-12-03 | 2021-12-01 | 4 | Kupfer David | NERV | Common Stock | D | 0.8800 | -55,635 | -49 | 163,553 | ||||
| 2021-06-16 | 2021-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 2.90 | 20,000 | 20,000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 2.90 | 40,000 | 40,000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 2.90 | 20,000 | 20,000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 2.90 | 20,000 | 20,000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 2.90 | 20,000 | 20,000 | |||||
| 2021-06-15 | 2021-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 2.90 | 20,000 | 20,000 | |||||
| 2020-12-16 | 2020-12-16 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 2.6400 | -3,228 | -9 | 31,747 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8,750 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8,750 | 34,975 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Race Geoff | NERV | Common Stock | D | 2.6400 | -6,190 | -16 | 211,354 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12,500 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12,500 | 217,544 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Luthringer Remy | NERV | Common Stock | D | 2.6400 | -1,300 | -3 | 66,490 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18,750 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18,750 | 67,790 | ||||||
| 2020-12-16 | 2020-12-16 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 2.6400 | -1,845 | -5 | 10,039 | ||||
| 2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5,000 | 0 | ||||||
| 2020-12-16 | 2020-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,000 | 11,884 | ||||||
| 2020-10-14 | 2020-10-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 3.50 | 200,000 | 200,000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 3.50 | 140,000 | 140,000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 3.50 | 85,000 | 85,000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 3.50 | 85,000 | 85,000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 3.50 | 100,000 | 100,000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 3.50 | 85,000 | 85,000 | |||||
| 2020-10-14 | 2020-10-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 3.50 | 85,000 | 85,000 | |||||
| 2020-09-11 | 2020-09-10 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 2.9700 | 7,000 | 21 | 20,333 | ||||
| 2020-08-17 | 2020-06-19 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7.11 | 153,531 | 153,531 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7.11 | 275,568 | 275,568 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7.11 | 137,784 | 137,784 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7.11 | 354,302 | 354,302 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7.11 | 153,531 | 153,531 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7.11 | 185,025 | 185,025 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7.11 | 236,202 | 236,202 | |||||
| 2020-08-17 | 2020-06-19 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7.11 | 137,784 | 137,784 | |||||
| 2020-06-12 | 2020-06-11 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 3.40 | 40,000 | 40,000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 3.40 | 20,000 | 20,000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 3.40 | 20,000 | 20,000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 3.40 | 20,000 | 20,000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 3.40 | 20,000 | 20,000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 3.40 | 20,000 | 20,000 | |||||
| 2020-05-27 | 2020-05-26 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 15.0000 | -8,339 | -125 | 6,884 | ||||
| 2020-01-03 | 2019-12-31 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7.11 | 74,432 | 74,432 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7.11 | 41,469 | 41,469 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7.11 | 49,975 | 49,975 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7.11 | 63,798 | 63,798 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7.11 | 41,469 | 41,469 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7.11 | 37,216 | 37,216 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7.11 | 37,216 | 37,216 | |||||
| 2020-01-03 | 2019-12-31 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7.11 | 95,698 | 95,698 | |||||
| 2019-12-17 | 2019-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7.1000 | -5,826 | -41 | 205,044 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12,500 | 12,500 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12,500 | 210,870 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7.1000 | -2,724 | -19 | 26,225 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8,750 | 8,750 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8,750 | 28,949 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7.1000 | -1,557 | -11 | 15,223 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5,000 | 5,000 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,000 | 16,780 | ||||||
| 2019-12-17 | 2019-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7.1000 | -2,412 | -17 | 49,040 | ||||
| 2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18,750 | 18,750 | ||||||
| 2019-12-17 | 2019-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18,750 | 51,452 | ||||||
| 2019-12-13 | 2019-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7.4200 | -3,113 | -23 | 33,770 | ||||
| 2019-07-01 | 2019-06-27 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 5.5000 | 3,500 | 19 | 26,111 | ||||
| 2019-06-27 | 2019-06-26 | 4 | Kupfer David | NERV | Common Stock | D | 5.5500 | 10,000 | 56 | 219,188 | ||||
| 2019-06-27 | 2019-06-26 | 4 | HASLER HANS PETER | NERV | Common Stock | D | 5.6000 | 10,000 | 56 | 10,000 | ||||
| 2019-06-27 | 2019-06-26 | 4 | HILLEMAN JERYL L | NERV | Common Stock | D | 5.2500 | 1,000 | 5 | 1,000 | ||||
| 2019-06-27 | 2019-06-26 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 5.3700 | 10,000 | 54 | 13,333 | ||||
| 2019-06-26 | 2019-06-24 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6.0144 | -197,000 | -1,185 | 3,899,189 | ||||
| 2019-06-21 | 2019-06-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.3413 | -33,575 | -146 | 4,096,189 | ||||
| 2019-06-21 | 2019-06-19 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.4425 | -77,243 | -343 | 4,129,764 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.4393 | -49,675 | -221 | 4,207,007 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.4487 | -56,243 | -250 | 4,256,682 | ||||
| 2019-06-17 | 2019-06-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.4971 | -25,169 | -113 | 4,312,925 | ||||
| 2019-06-17 | 2019-06-13 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.5133 | -53,298 | -241 | 4,338,094 | ||||
| 2019-06-13 | 2019-06-12 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.5719 | -26,901 | -123 | 4,391,392 | ||||
| 2019-06-13 | 2019-06-11 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 4.7769 | -33,150 | -158 | 4,418,293 | ||||
| 2019-06-13 | 2019-06-12 | 4 | DOYLE WILLIAM F | NERV | Stock option (right to buy) | D | 4.50 | 20,000 | 20,000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5.21 | 20,000 | 20,000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 5.21 | 20,000 | 20,000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 5.21 | 20,000 | 20,000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | HILLEMAN JERYL L | NERV | Stock Option (right to buy) | D | 5.21 | 20,000 | 20,000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | DOYLE WILLIAM F | NERV | Stock Option (right to buy) | D | 5.21 | 20,000 | 20,000 | |||||
| 2019-05-31 | 2019-05-31 | 4 | HASLER HANS PETER | NERV | Stock Option (right to buy) | D | 5.21 | 20,000 | 20,000 | |||||
| 2019-05-21 | 2019-05-20 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6.0750 | -200 | -1 | 4,451,443 | ||||
| 2019-05-21 | 2019-05-17 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6.0164 | -22,718 | -137 | 4,451,643 | ||||
| 2019-05-16 | 2019-05-16 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6.3715 | -44,836 | -286 | 4,474,361 | ||||
| 2019-05-16 | 2019-05-15 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 6.6357 | -53,418 | -354 | 4,519,197 | ||||
| 2019-05-16 | 2019-05-14 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 7.0548 | -36,574 | -258 | 4,572,615 | ||||
| 2018-12-26 | 2018-12-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 6.5000 | 2,000 | 13 | 22,611 | ||||
| 2018-12-18 | 2018-12-17 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 7.4600 | -2,728 | -20 | 20,199 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8,750 | 17,500 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8,750 | 22,927 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Luthringer Remy | NERV | Common Stock | D | 7.4600 | -2,604 | -19 | 32,702 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18,750 | 37,500 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18,750 | 35,306 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 7.4600 | -1,559 | -12 | 11,780 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5,000 | 10,000 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,000 | 13,339 | ||||||
| 2018-12-18 | 2018-12-17 | 4 | Race Geoff | NERV | Common Stock | D | 7.4600 | -5,999 | -45 | 198,370 | ||||
| 2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12,500 | 25,000 | ||||||
| 2018-12-18 | 2018-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12,500 | 204,369 | ||||||
| 2018-12-13 | 2018-12-12 | 4 | Russell Richard E. | NERV | Common Stock | D | 7.9600 | -3,117 | -25 | 36,883 | ||||
| 2018-12-13 | 2018-12-11 | 4 | Russell Richard E. | NERV | Employee Stock Option (right to buy) | D | 7.96 | 260,000 | 260,000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Saoud Jay | NERV | Employee Stock Option (right to buy) | D | 7.96 | 96,000 | 96,000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (right to buy) | D | 7.96 | 120,000 | 120,000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (right to buy) | D | 7.96 | 120,000 | 120,000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Davidson Michael | NERV | Employee Stock Option (right to buy) | D | 7.96 | 175,000 | 175,000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Luthringer Remy | NERV | Employee Stock Option (right to buy) | D | 7.96 | 410,000 | 410,000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Race Geoff | NERV | Employee Stock Option (right to buy) | D | 7.96 | 175,000 | 175,000 | |||||
| 2018-12-13 | 2018-12-11 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (right to buy) | D | 7.96 | 120,000 | 120,000 | |||||
| 2018-12-12 | 2018-12-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 7.9500 | 4,000 | 32 | 20,611 | ||||
| 2018-12-12 | 2018-12-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8.0000 | 2,000 | 16 | 16,611 | ||||
| 2018-11-21 | 2018-11-20 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 8.2000 | 2,000 | 16 | 14,611 | ||||
| 2018-10-15 | 2018-10-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10.0000 | 600 | 6 | 12,611 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 5.19 | -10,000 | 47,524 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4.71 | -15,000 | 27,400 | |||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12.6200 | -1,700 | -21 | 14,177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12.0200 | -23,300 | -280 | 15,877 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5.1900 | 10,000 | 52 | 39,177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4.7100 | 15,000 | 71 | 29,177 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12.3509 | -15,444 | -191 | 4,609,189 | ||||
| 2018-10-01 | 2018-09-28 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12.6151 | -34,589 | -436 | 4,624,633 | ||||
| 2018-10-01 | 2018-09-27 | 4 | Index Venture Associates III Ltd | NERV | Common Stock | I | 12.5702 | -31,684 | -398 | 4,659,222 | ||||
| 2018-09-19 | 2018-09-17 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10.5000 | 1,800 | 19 | 12,011 | ||||
| 2018-09-17 | 2018-09-14 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10.5000 | 200 | 2 | 10,211 | ||||
| 2018-09-17 | 2018-09-13 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 10.5000 | 2,000 | 21 | 10,011 | ||||
| 2018-09-11 | 2018-09-11 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9.7200 | 4,011 | 39 | 8,011 | ||||
| 2018-09-11 | 2018-09-10 | 4 | DOYLE WILLIAM F | NERV | Common Stock | D | 9.8800 | 4,000 | 40 | 4,000 | ||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 4.71 | -25,000 | 42,400 | |||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 10.0000 | -25,000 | -250 | 14,177 | ||||
| 2018-08-24 | 2018-08-23 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4.7100 | 25,000 | 118 | 39,177 | ||||
| 2018-08-02 | 2018-08-01 | 4 | Smith Devin Whittemore | NERV | Employee Stock Option (Righ to Buy) | D | 7.95 | 200,000 | 200,000 | |||||
| 2018-08-02 | 2018-08-01 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 7.95 | 20,000 | 20,000 | |||||
| 2018-07-17 | 2018-07-16 | 4 | HILLEMAN JERYL L | NERV | Stock Option (Right to Buy) | D | 8.20 | 40,000 | 40,000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 8.25 | 20,000 | 20,000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | DOYLE WILLIAM F | NERV | Stock Option (Right to Buy) | D | 8.25 | 20,000 | 20,000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | HASLER HANS PETER | NERV | Stock Option (Right to Buy) | D | 8.25 | 20,000 | 20,000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 8.25 | 20,000 | 20,000 | |||||
| 2018-06-11 | 2018-06-07 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 8.25 | 20,000 | 20,000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10.20 | 12,500 | 12,500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10.00 | 12,500 | 12,500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10.00 | -12,500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10.20 | -12,500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4.34 | 7,500 | 7,500 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 4.34 | -7,500 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6.00 | 127,513 | 127,513 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6.00 | -127,513 | 0 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9.49 | 80,356 | 80,356 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 9.49 | -80,356 | 0 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6.20 | 200,000 | 200,000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | -12,500 | 37,500 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 5.7900 | -5,829 | -34 | 191,869 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Race Geoff | NERV | Common Stock | D | 12,500 | 197,698 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6.10 | 200,000 | 200,000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6.10 | 175,000 | 175,000 | |||||
| 2017-12-15 | 2017-12-13 | 4 | Davidson Michael | NERV | Employee Stock Option (Right to Buy) | D | 6.10 | 125,000 | 125,000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | -5,000 | 15,000 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.8000 | -1,661 | -10 | 8,339 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5,000 | 10,000 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6.10 | 120,000 | 120,000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | -8,750 | 26,250 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 5.8000 | -2,906 | -17 | 14,177 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 8,750 | 17,083 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6.10 | 120,000 | 120,000 | |||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | -18,750 | 56,250 | ||||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 5.8500 | -2,194 | -13 | 16,556 | ||||
| 2017-12-15 | 2017-12-14 | 4 | Luthringer Remy | NERV | Common Stock | D | 18,750 | 18,750 | ||||||
| 2017-12-15 | 2017-12-13 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6.10 | 350,000 | 350,000 | |||||
| 2017-12-12 | 2017-12-10 | 4 | DOYLE WILLIAM F | NERV | Option Grant (Right to Buy) | D | 5.70 | 40,000 | 40,000 | |||||
| 2017-12-12 | 2017-12-10 | 4 | HASLER HANS PETER | NERV | Option Grant (Right to Buy) | D | 5.70 | 40,000 | 40,000 | |||||
| 2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Employee Stock option (Right to Buy) | D | 6.05 | 775,000 | 775,000 | |||||
| 2017-12-12 | 2017-12-11 | 4 | Russell Richard E. | NERV | Common Stock | D | 40,000 | 40,000 | ||||||
| 2017-09-14 | 2017-08-29 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 0.0001 | -3,892,256 | -0 | 0 | ||||
| 2017-09-05 | 2017-09-01 | 4 | Saoud Jay | NERV | Employee Stock Option (Right to Buy) | D | 6.45 | 100,000 | 100,000 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10.20 | 12,500 | 12,500 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10.00 | 12,500 | 12,500 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10.00 | -12,500 | 0 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10.20 | -12,500 | 0 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4.71 | 25,000 | 25,000 | |||||
| 2017-07-26 | 2017-07-24 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 4.71 | -25,000 | 0 | |||||
| 2017-06-05 | 2017-06-01 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 10.00 | 12,500 | 12,500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Vandervelpen Nico | NERV | Stock Option (Right to Buy) | D | 10.00 | 12,500 | 12,500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4.71 | -7,250 | 49,750 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 5.19 | -14,381 | 43,143 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 11.0000 | -10,381 | -114 | 5,000 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 10.0000 | -11,250 | -112 | 15,381 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4.7100 | 7,250 | 34 | 26,631 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 5.1900 | 14,381 | 75 | 19,381 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (Right to Buy) | D | 10.00 | 12,500 | 12,500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Kupfer David | NERV | Stock Option (Right to Buy) | D | 10.00 | 12,500 | 12,500 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 5.19 | -17,500 | 39,774 | |||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 11.0000 | -17,500 | -192 | 0 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Levine Mark S. | NERV | Common Stock | D | 5.1900 | 17,500 | 91 | 17,500 | ||||
| 2017-06-05 | 2017-06-01 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 10.00 | 12,500 | 12,500 | |||||
| 2017-03-21 | 2017-03-20 | 4 | Beer Marc D | NERV | Common Stock | D | 7.8900 | 25,000 | 197 | 50,000 | ||||
| 2017-03-21 | 2017-03-17 | 4 | Beer Marc D | NERV | Common Stock | D | 8.3400 | 25,000 | 208 | 25,000 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4.71 | -2,185 | 285,719 | |||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 11.0000 | -2,185 | -24 | 0 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Luthringer Remy | NERV | Common Stock | D | 4.7100 | 2,185 | 10 | 2,185 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 4.71 | -32,096 | 287,904 | |||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 11.0200 | -32,096 | -354 | 0 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Luthringer Remy | NERV | Common Stock | D | 4.7100 | 32,096 | 151 | 32,096 | ||||
| 2017-02-07 | 2017-02-06 | 4 | Race Geoff | NERV | Common Stock | D | 11.0000 | -1,692 | -19 | 185,198 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Race Geoff | NERV | Common Stock | D | 11.0200 | -19,758 | -218 | 186,890 | ||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Stock Option (Right to Buy) | D | 4.71 | -1,600 | 67,400 | |||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 12.0300 | -1,600 | -19 | 8,333 | ||||
| 2017-01-13 | 2017-01-11 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 4.7100 | 1,600 | 8 | 9,933 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 5.19 | -250 | 57,274 | |||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Stock Option (Right to Buy) | D | 4.71 | -17,250 | 51,750 | |||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 12.0000 | -17,500 | -210 | 0 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 5.1900 | 250 | 1 | 17,500 | ||||
| 2017-01-06 | 2017-01-04 | 4 | Levine Mark S. | NERV | Common Stock | D | 4.7100 | 17,250 | 81 | 17,250 | ||||
| 2017-01-05 | 2017-01-03 | 4 | Davidson Michael | NERV | Stock Option (Right to Buy) | D | 11.75 | 145,000 | 145,000 | |||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 4.71 | -12,000 | 57,000 | |||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 12.5100 | -17,000 | -213 | 5,000 | ||||
| 2016-12-29 | 2016-12-27 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 4.7100 | 12,000 | 57 | 22,000 | ||||
| 2016-12-20 | 3 | Davidson Michael | NERV | Common Stock | D | 0 | ||||||||
| 2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 13.45 | 35,000 | 35,000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Ahlholm Frederick W | NERV | Restricted Stock Unit | D | 20,000 | 20,000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 13.45 | 100,000 | 100,000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Race Geoff | NERV | Restricted Stock Unit | D | 50,000 | 50,000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Stock Option (Right to Buy) | D | 13.45 | 150,000 | 150,000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Luthringer Remy | NERV | Restricted Stock Unit | D | 75,000 | 75,000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 13.45 | 60,000 | 60,000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Reilly Joseph H. | NERV | Restricted Stock Unit | D | 35,000 | 35,000 | ||||||
| 2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 13.45 | 35,000 | 35,000 | |||||
| 2016-12-16 | 2016-12-14 | 4 | Levine Mark S. | NERV | Restricted Stock Units | D | 20,000 | 20,000 | ||||||
| 2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5.77 | -202,634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 5.7720 | 202,634 | 1,170 | 4,690,906 | ||||
| 2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5.77 | -202,634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 5.7720 | 202,634 | 1,170 | 4,690,906 | ||||
| 2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5.77 | -202,634 | 0 | |||||
| 2016-12-14 | 2016-12-12 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 5.7720 | 202,634 | 1,170 | 4,690,906 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 10.0000 | -1,000,000 | -10,000 | 4,488,272 | ||||
| 2016-08-12 | 2016-08-10 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 10.0000 | -1,000,000 | -10,000 | 4,488,272 | ||||
| 2016-08-12 | 2016-08-10 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 10.0000 | -1,000,000 | -10,000 | 4,488,272 | ||||
| 2016-06-21 | 2016-06-21 | 4 | Kupfer David By wife | NERV | Common Stock | I | 10.7250 | 27,935 | 300 | 27,935 | ||||
| 2016-06-21 | 2016-06-20 | 4 | Kupfer David | NERV | Common Stock | D | 10.9530 | 27,700 | 303 | 209,188 | ||||
| 2016-06-17 | 2016-06-16 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 10.20 | 12,500 | 12,500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 10.20 | 12,500 | 12,500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 10.20 | 12,500 | 12,500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 10.20 | 12,500 | 12,500 | |||||
| 2016-06-17 | 2016-06-16 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 10.20 | 12,500 | 12,500 | |||||
| 2016-03-18 | 2016-03-17 | 4 | Kupfer David | NERV | Common Stock | D | 5.5100 | 181,488 | 1,000 | 181,488 | ||||
| 2016-02-12 | 2015-03-18 | 5 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4.9300 | 607,903 | 2,997 | 3,892,256 | ||||
| 2015-12-08 | 2015-12-04 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 4.71 | 69,000 | 69,000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 4.71 | 69,000 | 69,000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 4.71 | 175,000 | 175,000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 4.71 | 320,000 | 320,000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 4.71 | 69,000 | 69,000 | |||||
| 2015-12-08 | 2015-12-04 | 4 | Vandervelpen Nico | NERV | Stock Option (right to buy) | D | 4.71 | 25,000 | 25,000 | |||||
| 2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
| 2015-11-03 | 3 | Kupfer David | NERV | Common Stock | D | 0 | ||||||||
| 2015-11-03 | 2015-11-02 | 4 | Kupfer David | NERV | Stock Option (right to buy) | D | 5.41 | 25,000 | 25,000 | |||||
| 2015-06-18 | 2015-06-17 | 4 | Laghrissi-Thode Fouzia | NERV | Stock Option (right to buy) | D | 25,000 | 25,000 | ||||||
| 2015-05-18 | 3 | Laghrissi-Thode Fouzia | NERV | Common Stock | D | 0 | ||||||||
| 2015-04-16 | 2015-02-02 | 4/A | Beer Marc D | NERV | Stock Option (right to buy) | D | 7,500 | 7,500 | ||||||
| 2015-04-16 | 2015-04-14 | 4 | Ahlholm Frederick W | NERV | Stock Option (right to buy) | D | 5.19 | 57,524 | 57,524 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Race Geoff | NERV | Stock Option (right to buy) | D | 5.19 | 213,133 | 213,133 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Luthringer Remy | NERV | Stock Option (right to buy) | D | 5.19 | 399,623 | 399,623 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Reilly Joseph H. | NERV | Stock Option (right to buy) | D | 5.19 | 57,524 | 57,524 | |||||
| 2015-04-16 | 2015-04-14 | 4 | Levine Mark S. | NERV | Stock Option (right to buy) | D | 5.19 | 57,524 | 57,524 | |||||
| 2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Warrant Shares | I | 5.77 | 0.1250 | 202,634 | 25 | 202,634 | |||
| 2015-03-20 | 2015-03-18 | 4 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 4.8100 | 202,634 | 975 | 5,488,272 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 6.2500 | -6,700 | -42 | 1,662,592 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5.7500 | -1,200,000 | -6,900 | 1,669,292 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Warrant Shares | I | 5.77 | 0.1250 | 202,634 | 25 | 202,634 | |||
| 2015-03-20 | 2015-03-18 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 4.8100 | 202,634 | 975 | 5,488,272 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Warrant Shares | I | 5.77 | 0.1250 | 202,634 | 25 | 202,634 | |||
| 2015-03-20 | 2015-03-18 | 4 | Index Venture Associates III Ltd See Footnotes | NERV | Common Stock | I | 4.8100 | 202,634 | 975 | 5,488,272 | ||||
| 2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation- JJDC, Inc. | NERV | Warrants (right to buy) | I | 5.77 | 0.1250 | 607,903 | 76 | 607,903 | |||
| 2015-03-17 | 2015-03-13 | 4 | JOHNSON & JOHNSON By Johnson & Johnson Innovation - JJDC, Inc. | NERV | Common Stock | I | 4.8100 | 607,903 | 2,924 | 4,500,159 | ||||
| 2015-02-04 | 2015-02-02 | 4 | VAN HEEK G JAN | NERV | Stock Option (right to buy) | D | 7,500 | 7,500 | ||||||
| 2015-02-04 | 2015-02-02 | 4 | Beer Marc D | NERV | Stock Option (right to buy) | D | 7,500 | 7,500 | ||||||
| 2015-01-26 | 2015-01-26 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5.0200 | -23,111 | -116 | 2,869,292 | ||||
| 2015-01-26 | 2015-01-23 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5.1400 | -63,304 | -325 | 2,892,403 | ||||
| 2015-01-26 | 2015-01-22 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5.1100 | -395,697 | -2,022 | 2,955,707 | ||||
| 2015-01-08 | 2015-01-08 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5.6600 | -70,659 | -400 | 3,351,404 | ||||
| 2015-01-08 | 2015-01-07 | 4 | Care Capital III LLC | NERV | Common Stock | I | 5.8500 | -64,278 | -376 | 3,422,063 | ||||
| 2015-01-08 | 2015-01-06 | 4 | Care Capital III LLC | NERV | Common Stock | I | 7.9400 | -396,871 | -3,151 | 3,486,341 | ||||
| 2014-09-03 | 2014-09-02 | 4 | Levine Mark S. | NERV | Employee Stock Option (Right to Buy) | D | 7.10 | 93,541 | 93,541 | |||||
| 2014-09-03 | 3 | Vandervelpen Nico | NERV | No securities are beneficially owned. | D | 0 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6,568,706 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6,568,706 | ||||||||
| 2014-07-17 | 3 | Johnson & Johnson Innovation - JJDC, Inc. By Johnson & Johnson Development Corporation | NERV | Common Stock | I | 6,568,706 | ||||||||
| 2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6.00 | 207,869 | 649,842 | |||||
| 2014-07-11 | 2014-06-30 | 4 | Luthringer Remy | NERV | Employee Stock Option (Right to Buy) | D | 6.00 | 441,973 | 441,973 | |||||
| 2014-07-09 | 2014-06-30 | 4 | Beer Marc D | NERV | Stock Option (Right to Buy) | D | 6.00 | 127,513 | 127,513 | |||||
| 2014-07-09 | 2014-07-01 | 4 | VAN HEEK G JAN | NERV | Common Stock | D | 6.0000 | 3,333 | 20 | 3,333 | ||||
| 2014-07-09 | 2014-06-30 | 4 | VAN HEEK G JAN | NERV | Stock Option (Right to Buy) | D | 6.00 | 51,967 | 51,967 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -61,922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -114,077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.0000 | 333,333 | 2,000 | 5,285,638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.0000 | 1,287,500 | 7,725 | 4,952,305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.0000 | 61,922 | 372 | 3,664,805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6.0000 | 114,077 | 684 | 3,602,883 | ||||
| 2014-07-09 | 2014-07-01 | 4 | Ahlholm Frederick W | NERV | Common Stock | D | 6.0000 | 10,000 | 60 | 10,000 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Ahlholm Frederick W | NERV | Employee Stock Option (Right to Buy) | D | 6.00 | 93,541 | 93,541 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -61,923 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -114,078 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6.0000 | 737,500 | 4,425 | 3,883,212 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6.0000 | 61,923 | 372 | 3,145,712 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Care Capital III LLC See footnotes | NERV | Common Stock | I | 6.0000 | 114,078 | 684 | 3,083,789 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -61,922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -114,077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6.0000 | 333,333 | 2,000 | 5,285,638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6.0000 | 1,287,500 | 7,725 | 4,952,305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6.0000 | 61,922 | 372 | 3,664,805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | De Rubertis Francesco See footnotes | NERV | Common Stock | I | 6.0000 | 114,077 | 684 | 3,602,883 | ||||
| 2014-07-09 | 2014-07-01 | 4 | Vivaldi Coelho Rogerio | NERV | Common Stock | D | 6.0000 | 41,667 | 250 | 41,667 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Vivaldi Coelho Rogerio | NERV | Employee Stock Option (right to buy) | D | 6.00 | 498,621 | 498,621 | |||||
| 2014-07-09 | 2014-07-01 | 4 | Race Geoff | NERV | Common Stock | D | 6.0000 | 33,333 | 200 | 206,648 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6.00 | 249,442 | 346,585 | |||||
| 2014-07-09 | 2014-06-30 | 4 | Race Geoff | NERV | Employee Stock Option (Right to Buy) | D | 6.00 | 97,143 | 97,143 | |||||
| 2014-07-09 | 2014-07-01 | 4 | Reilly Joseph H. | NERV | Common Stock | D | 6.0000 | 8,333 | 50 | 8,333 | ||||
| 2014-07-09 | 2014-06-30 | 4 | Reilly Joseph H. | NERV | Employee Stock Option (Right to Buy) | D | 6.00 | 93,541 | 93,541 | |||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -61,923 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -114,078 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6.0000 | 737,500 | 4,425 | 3,883,212 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6.0000 | 61,923 | 372 | 3,145,712 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Pellegrini Lorenzo See footnotes | NERV | Common Stock | I | 6.0000 | 114,078 | 684 | 3,083,789 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -61,922 | -372 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Convertible Promissory Note | I | 6.00 | 6.0000 | -114,077 | -684 | 0 | |||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6.0000 | 333,333 | 2,000 | 5,285,638 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6.0000 | 1,287,500 | 7,725 | 4,952,305 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6.0000 | 61,922 | 372 | 3,664,805 | ||||
| 2014-07-09 | 2014-07-07 | 4 | Index Venture Associates III Ltd See footnotes | NERV | Common Stock | I | 6.0000 | 114,077 | 684 | 3,602,883 | ||||
| 2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | Ollier Michele See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5,939,422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5,939,422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5,939,422 | ||||||||
| 2014-06-30 | 3 | Care Capital Offshore Investments III LP See Footnotes | NERV | Common Stock | I | 5,939,422 | ||||||||
| 2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | De Rubertis Francesco See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346,630 | ||||||||
| 2014-06-30 | 3 | Race Geoff | NERV | Common Stock | D | 346,630 | ||||||||
| 2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1,853,208 | ||||||||
| 2014-06-30 | 3 | Luthringer Remy By Wint2felden Holding SA | NERV | Common Stock | I | 1,853,208 | ||||||||
| 2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5,939,422 | ||||||||
| 2014-06-30 | 3 | Pellegrini Lorenzo See Footnotes | NERV | Common Stock | I | 5,939,422 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6,873,796 | ||||||||
| 2014-06-30 | 3 | Index Venture Associates V Ltd See Footnotes | NERV | Common Stock | I | 6,873,796 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
